Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

PBSC mobilization in newly diagnosed patients with POEMS syndrome: outcomes and prognostic factors.

Li J, Zhang W, Duan MH, Jiao L, Zhu TN, Han B, Zhang L, Gan J, Zhou DB.

Bone Marrow Transplant. 2013 Feb;48(2):233-7. doi: 10.1038/bmt.2012.138. Epub 2012 Jul 23.

PMID:
22825426
2.

Peripheral blood hematopoietic stem cell mobilization and collection efficacy is not an independent prognostic factor for autologous stem cell transplantation.

Wang S, Nademanee A, Qian D, Dagis A, Park HS, Fridey J, Smith E, Snyder D, Somlo G, Stein A, Rosenthal J, Falk P, Kogut N, Palmer J, Gaal K, Kim Y, Bhatia R, Yuan S, Kay C, Weiss L, Forman S.

Transfusion. 2007 Dec;47(12):2207-16. Epub 2007 Aug 21.

PMID:
17714420
4.

Mobilization of PBSCs in poor mobilizers with POEMS syndrome using G-CSF with plerixafor.

Shimizu N, Sakaida E, Ohwada C, Takeuchi M, Kawaguchi T, Tsukamoto S, Sakai S, Takeda Y, Sugita Y, Yokote K, Iseki T, Isose S, Kanai K, Misawa S, Kuwabara S, Nakaseko C.

Bone Marrow Transplant. 2012 Dec;47(12):1587-8. doi: 10.1038/bmt.2012.80. Epub 2012 May 21. No abstract available.

PMID:
22609884
5.

Peripheral blood stem cell mobilization by granulocyte colony-stimulating factor alone and engraftment kinetics following autologous transplantation in children and adolescents with solid tumor.

Watanabe H, Watanabe T, Suzuya H, Wakata Y, Kaneko M, Onishi T, Okamoto Y, Abe T, Kawano Y, Kagami S, Takaue Y.

Bone Marrow Transplant. 2006 Apr;37(7):661-8.

PMID:
16489358
6.
7.

Impact of mobilization and remobilization strategies on achieving sufficient stem cell yields for autologous transplantation.

Pusic I, Jiang SY, Landua S, Uy GL, Rettig MP, Cashen AF, Westervelt P, Vij R, Abboud CN, Stockerl-Goldstein KE, Sempek DS, Smith AL, DiPersio JF.

Biol Blood Marrow Transplant. 2008 Sep;14(9):1045-56. doi: 10.1016/j.bbmt.2008.07.004.

8.

Impact of chemotherapy regimen and hematopoietic growth factor on mobilization and collection of peripheral blood stem cells in cancer patients.

Nowrousian MR, Waschke S, Bojko P, Welt A, Schuett P, Ebeling P, Flasshove M, Moritz T, Schuette J, Seeber S.

Ann Oncol. 2003;14 Suppl 1:i29-36.

10.
11.

[Clinical study on high-dose etoposide with granulocyte colony-stimulating factor for mobilization of autologous peripheral blood stem cells in patients with hematologic malignancies].

Shen WY, Li JY, Hong M, Zhang R, Lu H, Liu P, Qian SX, Xu W, Qiu HX, Wu HX.

Zhonghua Xue Ye Xue Za Zhi. 2012 Aug;33(8):628-31. Chinese.

PMID:
23134856
12.

Intermediate-dose versus low-dose cyclophosphamide and granulocyte colony-stimulating factor for peripheral blood stem cell mobilization in patients with multiple myeloma treated with novel induction therapies.

Hamadani M, Kochuparambil ST, Osman S, Cumpston A, Leadmon S, Bunner P, Watkins K, Morrison D, Speir E, Deremer D, Kota V, Jillella A, Craig M, Awan F.

Biol Blood Marrow Transplant. 2012 Jul;18(7):1128-35. doi: 10.1016/j.bbmt.2012.01.005. Epub 2012 Jan 14.

13.

[Clinical analysis of peripheral blood stem cell mobilization regimens in autologous transplantation for treating non-Hodgkin's lymphoma].

Huang SY, Liu L, Hao MW, Yin DD, Wu YL, Chen RA, Li GH, Lui Q, Wang JC, He H, Liang YM.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2011 Dec;19(6):1415-8. Chinese.

PMID:
22169294
14.

Plerixafor plus granulocyte colony-stimulating factor versus placebo plus granulocyte colony-stimulating factor for mobilization of CD34(+) hematopoietic stem cells in patients with multiple myeloma and low peripheral blood CD34(+) cell count: results of a subset analysis of a randomized trial.

Nademanee AP, DiPersio JF, Maziarz RT, Stadtmauer EA, Micallef IN, Stiff PJ, Hsu FJ, Bridger G, Bolwell BJ.

Biol Blood Marrow Transplant. 2012 Oct;18(10):1564-72. doi: 10.1016/j.bbmt.2012.05.017. Epub 2012 Jun 6.

15.

Plerixafor as first- and second-line strategies for autologous stem cell mobilization in patients with non-Hodgkin's lymphoma or multiple myeloma.

Lor KW, Helmons PJ, Belew H, Lane JR, Ball ED.

Pharmacotherapy. 2012 Jul;32(7):596-603. doi: 10.1002/j.1875-9114.2012.01096.x.

PMID:
22760691
16.
18.

Factors associated with the efficiency of PBSC collection in POEMS syndrome patients undergoing autologous PBSC transplantation.

Shimizu N, Nakaseko C, Sakaida E, Ohwada C, Takeuchi M, Kawaguchi T, Tsukamoto S, Sakai S, Takeda Y, Abe D, Yokote K, Iseki T, Kanai K, Misawa S, Kuwabara S.

Bone Marrow Transplant. 2012 Jul;47(7):1010-2. doi: 10.1038/bmt.2011.211. Epub 2011 Oct 31. No abstract available.

PMID:
22041850
19.

High-dose therapy followed by autologous peripheral-blood stem-cell transplantation for patients with Hodgkin's disease and non-Hodgkin's lymphoma using unprimed and granulocyte colony-stimulating factor-mobilized peripheral-blood stem cells.

Nademanee A, Sniecinski I, Schmidt GM, Dagis AC, O'Donnell MR, Snyder DS, Parker PM, Stein AS, Smith EP, Molina A, et al.

J Clin Oncol. 1994 Oct;12(10):2176-86.

PMID:
7523609
20.

Clinical characteristics and long-term outcome of patients with POEMS syndrome in China.

Li J, Zhou DB, Huang Z, Jiao L, Duan MH, Zhang W, Zhao YQ, Shen T.

Ann Hematol. 2011 Jul;90(7):819-26. doi: 10.1007/s00277-010-1149-0. Epub 2011 Jan 8.

PMID:
21221584
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk